Cell death in rheumatoid arthritis

被引:183
作者
Korb, Adelheid [2 ]
Pavenstaedt, Hermann [2 ]
Pap, Thomas [1 ]
机构
[1] Univ Hosp Muenster, Inst Expt Musculoskeletal Med, D-48149 Munster, Germany
[2] Univ Hosp Muenster, Dept Internal Med Nephrol & Rheumatol, D-48149 Munster, Germany
关键词
Apoptosis; Rheumatoid arthritis; Fibroblasts; SUMO; Fas; TRAIL; synovial; TUMOR-NECROSIS-FACTOR; FIBROBLAST-LIKE-SYNOVIOCYTES; FAS-INDUCED APOPTOSIS; ALPHA-MEDIATED APOPTOSIS; SYNOVIAL FIBROBLASTS; SUMO-1; MODIFICATION; TRANSCRIPTIONAL RESPONSE; BCL-2; EXPRESSION; MODIFIER SUMO-1; TRAIL-R2; DR5;
D O I
10.1007/s10495-009-0317-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Apoptosis plays a pivotal role in tissue homoeostasis both under physiological and pathological conditions and several studies have shown that some characteristic changes in the composition and structure of the inflamed synovial membrane in rheumatoid arthritis (RA) are linked to an altered apoptotic response of synovial cells. As a result, a hyperplastic synovial tissue is generated that mediates the progressive destruction of articular cartilage and bone. In addition to inflammatory cells, these changes most prominently affect resident fibroblast-like cells that have been demonstrated to be of utmost importance for joint destruction. Once activated, these cells pass through prominent molecular changes resulting in an aggressive, invasive behaviour. Research of the past years has identified different mechanisms that prevent synovial cells in RA from apoptosis. They include changes in the mitochondrial pathway as well as altered expression of downstream modulators of death receptors and transcriptional regulators such as NFkappaB. This review summarises our recent progress in understanding aberrant apoptosis in the RA synovial membrane and points to possibilities of intervening specifically with this aspect of the pathogenesis of RA.
引用
收藏
页码:447 / 454
页数:8
相关论文
共 62 条
[1]
BAFF synthesis by rheumatoid synoviocytes is positively controlled by α5β1 integrin stimulation and is negatively regulated by tumor necrosis factor a and toll-like receptor ligands [J].
Alsaleh, Ghada ;
Messer, Laurent ;
Semaan, Noha ;
Boulanger, Nathalie ;
Gottenberg, Jacques-Eric ;
Sibilia, Jean ;
Wachsmann, Dominique .
ARTHRITIS AND RHEUMATISM, 2007, 56 (10) :3202-3214
[2]
NF-κB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor α-mediated apoptosis [J].
Bai, SC ;
Liu, HT ;
Chen, KH ;
Eksarko, P ;
Perlman, H ;
Moore, TL ;
Pope, RM .
ARTHRITIS AND RHEUMATISM, 2004, 50 (12) :3844-3855
[3]
Apoptosis in rheumatoid arthritis [J].
Baier, A ;
Meineckel, I ;
Gay, S ;
Pap, T .
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (03) :274-279
[4]
Structure determination of the small ubiquitin-related modifier SUMO-1 [J].
Bayer, P ;
Arndt, A ;
Metzger, S ;
Mahajan, R ;
Melchior, F ;
Jaenicke, R ;
Becker, J .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 280 (02) :275-286
[5]
Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium [J].
Catrina, AI ;
Ulfgren, AK ;
Lindblad, S ;
Grondal, L ;
Klareskog, L .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) :934-936
[6]
SUMO-1 modification of IκBα inhibits NF-κB activation [J].
Desterro, JMP ;
Rodriguez, MS ;
Hay, RT .
MOLECULAR CELL, 1998, 2 (02) :233-239
[7]
Gene transfer of tissue inhibitor of metalloproteinases-3 reverses the inhibitory effects of TNF-α on fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts [J].
Drynda, A ;
Quax, PHA ;
Neumann, M ;
van der Laan, WH ;
Pap, G ;
Drynda, S ;
Meinecke, I ;
Kekow, J ;
Neumann, W ;
Huizinga, TWJ ;
Naumann, M ;
König, W ;
Pap, T .
JOURNAL OF IMMUNOLOGY, 2005, 174 (10) :6524-6531
[8]
Evolving concepts of rheumatoid arthritis [J].
Firestein, GS .
NATURE, 2003, 423 (6937) :356-361
[9]
APOPTOSIS IN RHEUMATOID-ARTHRITIS SYNOVIUM [J].
FIRESTEIN, GS ;
YEO, M ;
ZVAIFLER, NJ .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) :1631-1638
[10]
Franz JK, 2000, ARTHRITIS RHEUM, V43, P599, DOI 10.1002/1529-0131(200003)43:3<599::AID-ANR17>3.0.CO